Febrikast 30mg Oral Suspension
By Febrikast
Rx
60ml Oral Suspension in a Bottle

Composition
Fexofenadine(30mg)

Manufacturer - Human Biolife India Pvt Ltd
Plot No 303, Industrial Area Phase -2, Panchkula (Haryana)-134109

Expires on or after
October, 2025

liver
Febrikast 30mg Oral Suspension may be considered safe for individuals with liver disease based on the available information. It appears that adjusting the dose of Febrikast 30mg Oral Suspension may not be necessary for these patients. However, it is crucial to consult with your healthcare provider for personalized guidance and appropriate monitoring while using this medication.

kidney
Febrikast 30mg Oral Suspension should be used carefully in patients with kidney disease. Adjustment of dosage may be necessary. Consult your doctor before use. It may lead to increased drowsiness in those with end stage kidney disease.

alcohol
It is not known if it is safe to drink alcohol with Febrikast 30mg Oral Suspension. Consult your doctor.

driving
Febrikast 30mg Oral Suspension typically does not impact driving ability. However, ensure it doesn't cause drowsiness or dizziness before driving or using machinery.

pregnancy
Febrikast 30mg Oral Suspension may not be safe for use during pregnancy. Limited human studies indicate potential harm to the developing baby based on animal studies. Consult your doctor for a thorough evaluation of benefits and risks before use.

breastfeeding
Febrikast 30mg Oral Suspension is considered safe for use during breastfeeding. Studies show minimal transfer to breastmilk, making it unlikely to affect the baby. No significant adverse effects are expected in breastfed babies due to low levels and lack of sedation from this medication.
Habit Forming | No |
Chemical Class | Diphenylmethane Derivative |
Therapeutic Class | RESPIRATORY |
Action Class | H1 Antihistaminics (second Generation) |
₹79
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024